Diagnostic Device Contract Manufacturing Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The diagnostic device contract manufacturing market encompasses outsourced production services for a wide range of medical diagnostic equipment, from molecular diagnostic platforms and immunoassay systems to point-of-care devices and imaging components. In 2025, the market is valued at approximately $34.4 billion, with projections indicating sustained expansion at a compound annual growth rate near 10% through 2030. The in vitro diagnostics manufacturing segment alone represents a significant portion of this market, having been valued at roughly $21 billion in recent assessments, highlighting the dominance of IVD-related production within the broader diagnostic contract manufacturing space.

• •Market valued at approximately $34.4 billion in 2025 with projected CAGR near 10% through 2030
• •IVD manufacturing segment estimated at roughly $21 billion, representing a major share of the overall diagnostic market
• •Broader medical device contract manufacturing market ranges from approximately $84 billion to $143 billion depending on scope and methodology

Several interconnected factors are fueling expansion across the diagnostic device contract manufacturing sector. The rising global burden of chronic and infectious diseases, combined with aging populations in developed and emerging economies, is driving increased demand for diagnostic testing and, consequently, for the devices that enable it. Additionally, healthcare providers and diagnostic companies are increasingly outsourcing manufacturing to specialized contract partners to capitalize on their advanced production capabilities, regulatory expertise, and economies of scale, allowing original equipment manufacturers to focus on research, development, and commercialization.

• •Growing prevalence of chronic diseases and aging populations driving higher diagnostic testing volumes worldwide
• •Ongoing trend of outsourcing among diagnostic OEMs seeking cost efficiencies, regulatory compliance expertise, and faster time-to-market
• •Advances in diagnostic technologies, including molecular diagnostics, point-of-care testing, and personalized medicine, creating demand for sophisticated manufacturing capabilities

The market can be broadly segmented by product type, including IVD instruments, point-of-care diagnostic devices, molecular diagnostic systems, and imaging and radiology equipment, with IVD manufacturing representing the largest category. Service offerings range from complete device manufacturing and assembly to component fabrication, design support, regulatory consulting, and post-market support services. Geographically, North America and Europe currently hold the largest market shares, supported by mature healthcare infrastructures, strong R&D ecosystems, and stringent regulatory frameworks that encourage partnerships with experienced contract manufacturers.

• •IVD instruments and consumables represent the dominant segment within diagnostic device contract manufacturing
• •Service categories span full-scale production, component manufacturing, design and engineering support, and regulatory compliance services
• •North America and Europe lead in market share, while Asia-Pacific is the fastest-growing region due to expanding healthcare access and manufacturing capacity

What are the recent trends and outlook?

Looking ahead, the diagnostic device contract manufacturing market is expected to maintain robust growth momentum, supported by continued innovation in diagnostic technologies and the persistent shift toward outsourcing among OEMs. Emerging trends include growing demand for miniaturized and portable diagnostic devices, the integration of artificial intelligence and connectivity features into diagnostic instruments, and increasing emphasis on localized manufacturing to supply chain resilience. As the market approaches the latter half of the decade, contract manufacturers that demonstrate agility, regulatory proficiency, and technological sophistication are positioned to capture a disproportionate share of expanding demand.

• •Projected market expansion to approximately $56 billion by 2030 if current growth trajectories hold
• •Rising adoption of point-of-care and at-home diagnostic solutions driving demand for compact, consumer-friendly device manufacturing
• •Supply chain regionalization and near-shoring trends influencing manufacturing footprint decisions among both OEMs and contract manufacturers